NCAP is recruiting North Carolina pharmacies to participate in a statewide REMS certification initiative for long-acting injectable buprenorphine (LAI-B) from May–September 2026.
With pharmacists now authorized to administer LAIs, pharmacies can help expand access to treatment for Opioid Use Disorder and support recovery in their communities.
Interested in participating? Click here to complete the interest form to learn more.
